Acetazolamide
NDC 70954-034, Acetazolamide, tablet, from ANI Pharmaceuticals, Inc..
- Product NDC
- 70954-034
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210588
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70954-034 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETAZOLAMIDE250 mg/1
Pharmacologic classes
Carbonic Anhydrase Inhibitor [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Sulfonamides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70954-034-20 | 70954003420 | 1000 TABLET in 1 BOTTLE (70954-034-20) |
| 70954-034-30 | 70954003430 | 100 TABLET in 1 BOTTLE (70954-034-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bde94a48-05d0-45a0-a589-ec05b7d16532NADAC price for package 70954003430
GET /v1/drugs/nadac/70954003430
Use it
Look up 70954-034 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70954-034 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70954-034. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.